Newsroom | 63517 results

AUCKLAND, New Zealand--(BUSINESS WIRE)--HPE (NYSE:HPE) today announced that Earth Sciences New Zealand (formally NIWA) of Aotearoa (New Zealand) selected HPE Cray XD2000, purpose-built for AI and simulation workloads, to accelerate the organization’s environmental science and precision of meteorological forecasting. The new system, named Cascade, replaces Earth Sciences New Zealand’s aging high performance computing (HPC) and delivers a threefold increase in computational power for researchers...

RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph) injection for subcutaneous administration in adults across most solid tumor indications for KEYTRUDA® (pembrolizumab). Berahyaluronidase alfa is a variant of human hyaluronidase developed and manufactured by Alteogen Inc. KEYTRUDA QLEX must be administer...

YOKOHAMA, Japan--(BUSINESS WIRE)--Het 2028 Internationale Congres van de International Society of Blood Transfusion (ISBT 2028) vindt plaats in Yokohama van 4 tot 8 juni 2028. Het wordt georganiseerd door ISBT en de Japan Society of Transfusion Medicine and Cell Therapy (JSTMCT). Na drie eerdere internationale (1960, 1996) en regionale congressen (2009) in Japan, keert het evenement na 19 jaar terug naar Japan. De succesvolle kandidatuur van JSTMCT om ISBT 2028 te organiseren werd ondersteund d...

YOKOHAMA, Giappone--(BUSINESS WIRE)--Il congresso internazionale 2028 dell'International Society of Blood Transfusion (ISBT 2028) si svolgerà a Yokohama dal 4 all'8 giugno 2028. Organizzato congiuntamente dall'ISBT e dalla Japan Society of Transfusion Medicine and Cell Therapy (JSTMCT), segna il ritorno in Giappone di questo evento a distanza di 19 anni, dopo tre precedenti congressi, sia internazionali (1960 e 1996) che regionali (2009), organizzati nel paese asiatico. In collaborazione con la...

YOKOHAMA, Japon--(BUSINESS WIRE)--Le Congrès international 2028 de la Société internationale de transfusion sanguine (2028 International Congress of the International Society for Blood Transfusion, ISBT 2028) se tiendra à Yokohama du 4 au 8 juin 2028. Organisé conjointement par l’ISBT et la Japan Society of Transfusion Medicine and Cell Therapy (JSTMCT), ce congrès marquera le retour de l’événement au Japon après 19 ans, après trois congrès déjà tenus dans le pays, dont deux internationaux (196...

YOKOHAMA, Japón--(BUSINESS WIRE)--El Congreso Internacional 2028 de la International Society of Blood Transfusion (ISBT 2028) se celebrará en Yokohama del 4 al 8 de junio de 2028, y estará organizado conjuntamente por la ISBT y la Japan Society of Transfusion Medicine and Cell Therapy (JSTMCT). Este evento marca el regreso a Japón después de 19 años, tras tres congresos internacionales (1960, 1996) y regionales (2009) celebrados anteriormente en el país. En colaboración con la ciudad de Yokoham...

YOKOHAMA, Japan--(BUSINESS WIRE)--Der International Congress of the International Society of Blood Transfusion (ISBT 2028) findet vom 4. bis 8. Juni 2028 in Yokohama statt. Die Veranstaltung wird gemeinsam von der ISBT und der Japan Society of Transfusion Medicine and Cell Therapy (JSTMCT) organisiert und kehrt damit nach 19 Jahren nach Japan zurück, nachdem zuvor bereits drei internationale Kongresse (1960, 1996) und regionale Kongresse (2009) in diesem Land stattgefunden hatten. In Zusammenar...

ROCKVILLE, Md.--(BUSINESS WIRE)--BIOQUAL, Inc. www.bioqual.com BIOQ(Pinksheets):     2025     2024   Revenue $ 48,867,753   $ 58,590,949   (Loss) Income Before Income Tax $ (1,896,010 ) $ 476,447   Net (Loss) Income $ (1,048,154 ) $ 483,481   Basic Earnings per Share of Common Stock $ (1.17 ) $ .54   Diluted Earnings per Share of Common Stock $ (1.17 ) $ .54   Weighted Average           Number of Shares Outstanding           For Basic Earnings Per Share   894,416     894,416   Weighted Average...

YOKOHAMA, Japan--(BUSINESS WIRE)--The 2028 International Congress of the International Society of Blood Transfusion (ISBT 2028) will be held in Yokohama, Japan....

HYOGO, Japan--(BUSINESS WIRE)--JCR announced that is has achieved a key research milestone in one of its collaborative programs with Alexion, AstraZeneca Rare Disease....